Pyoderma gangrenosum is a rare skin disease where the body’s immune system attacks the skin by mistake and creates very painful open sores called ulcers. These ulcers usually start as small red or purple bumps or pustules that look like acne or a bug bite. They then break down quickly and turn into deep, wide ulcers with soft, undermined, purple-blue edges and a raw, dirty-looking base. The sores most often appear on the lower legs, but they can happen anywhere, including around surgical wounds and around stomas on the belly. The condition is not an infection, even though the ulcers may ooze and look infected. It is not cancer and it is not contagious. Doctors call PG a “neutrophilic dermatosis,” which means white blood cells (neutrophils) flood the skin and cause damage even when there is no germ to fight. The key idea in simple words is that the immune system gets overexcited and harms your own skin, which makes a painful ulcer that can grow fast and gets worse if the area is injured again.
Pyoderma gangrenosum is a rare, painful skin disease that makes rapidly growing ulcers. The ulcers usually start as small tender bumps or blisters and then break down into open sores with purple-red, undermined edges. PG is not an infection and not contagious. It happens because the immune system becomes overactive and causes deep skin inflammation. Doctors group PG with other neutrophilic dermatoses, which means the body’s neutrophil white cells drive much of the inflammation. PG often affects the legs, but it can occur anywhere, including around a stoma (peristomal PG). It is commonly linked with other diseases like inflammatory bowel disease (IBD), arthritis, and some blood disorders, so doctors also look for those conditions. Gentle care and correct treatment can control it, but it can take time to heal and may leave scars. DermNet®Bad AssociationNCBI
PG is mostly a diagnosis of exclusion, which means doctors first rule out other, more common causes of ulcers—like poor blood flow, blood clots, diabetes-related nerve damage, pressure injury, vasculitis, or true bacterial or fungal infections. Many people with PG also have another inflammatory condition in the body, such as inflammatory bowel disease, arthritis, or a blood disorder. For this reason, doctors do a careful whole-body check and blood tests to look for partner diseases that often travel with PG. Treatment needs medical care because the main medicines quiet the immune system, and the skin must be protected very gently since new injuries can trigger new ulcers. That tendency to worsen after even small injuries is called pathergy. In very simple terms, PG means the skin is already angry, and any bump or cut can make it angrier, so soft handling is essential.
Types of pyoderma gangrenosum
Classic (ulcerative) PG
This is the most common type. It starts as a tender red or purple bump that quickly breaks down into a deep, painful ulcer with purple-blue, undermined edges and a raw base that may ooze. It often shows up on the lower legs but can occur anywhere. It grows fast and hurts a lot.Atypical or bullous PG
This type makes thin-roofed blisters that pop and leave shallow but very painful erosions. It can appear on the upper body, arms, or face. It may be linked with blood problems like leukemia or myelodysplastic syndromes. The key look is fragile blisters that collapse and ulcerate quickly.Pustular PG
This type shows many small, very tender, pus-filled bumps and tiny erosions rather than one big ulcer. It often flares when inflammatory bowel disease is active. The spots are shallow but painful and can merge into larger areas.Vegetative (superficial granulomatous) PG
This is a milder form. It tends to form thick, warty, raised plaques that ulcerate only a little. It grows more slowly, is less painful, and often appears on the trunk. It usually responds to milder treatments.Peristomal PG
This type occurs around a stoma (for example, a colostomy opening). The skin around the bag gets very painful and breaks down into ulcers that can spread under the adhesive. Careful stoma fitting and gentle skin protection are essential.Post-surgical (surgery-triggered) PG
Here, a surgical incision or even a minor procedure starts a PG ulcer through the pathergy effect. The wound looks infected but cultures can be negative, and it keeps breaking down despite antibiotics, which is a clue to PG.Drug-associated or trigger-related PG
Rarely, certain medicines or exposures seem to trigger PG-like ulcers in some people. When the trigger is removed and the immune system is calmed, the ulcers can improve.Childhood (pediatric) PG
PG can occur in children, sometimes linked with autoinflammatory syndromes. The sores look similar but doctors also think about rare genetic causes and treat gently with specialist care.
Causes and strong associations
PG does not have a single simple cause. Think of it as an immune system error that can be pushed by certain body conditions, genes, or triggers. Below are 20 well-known drivers and partners that can set the stage:
Overactive innate immunity – the “first responder” arm of the immune system fires too hard and damages skin.
Neutrophil dysfunction – neutrophils swarm into the skin and release enzymes and signals that eat away tissue.
Pathergy (injury sensitivity) – small bumps, biopsies, injections, or surgeries can ignite new ulcers.
Inflammatory bowel disease (ulcerative colitis) – a common partner disease; skin flares can mirror gut flares.
Inflammatory bowel disease (Crohn’s disease) – similar link; controlling gut inflammation often helps skin.
Rheumatoid arthritis – joint inflammation and immune mis-targeting can travel with PG.
Seronegative spondyloarthritis and related arthritides – immune-driven joint conditions can associate with PG.
Hematologic cancers (e.g., leukemia, myelodysplastic syndrome) – blood cell disorders sometimes pair with atypical PG.
Monoclonal gammopathy and multiple myeloma – abnormal proteins in the blood can be linked with PG in some cases.
Hidradenitis suppurativa – a chronic boil-like skin disease that shares autoinflammatory pathways with PG.
PAPA / PASH / PAPASH syndromes (genetic autoinflammatory states) – rare gene variants can promote PG.
Recent surgery or trauma – the wound can be a spark for PG rather than a normal infection.
Infections as immune triggers (not the direct cause) – some infections ignite the immune system and PG follows.
Certain medications (rare, case-based) – examples reported include G-CSF, interferons, tyrosine kinase inhibitors, and cocaine adulterated with levamisole.
Pregnancy or postpartum immune shifts – big immune changes may play a role in select cases.
Active systemic inflammation of any cause – a primed immune system is more likely to misfire in the skin.
Metabolic stress (e.g., uncontrolled diabetes) as a co-factor – slows healing and complicates the picture.
Poor local circulation or venous disease as confounders – not a cause of PG but can worsen ulcers once PG begins.
Smoking and obesity – increase overall inflammation and make wounds harder to heal.
Idiopathic (unknown) – in many people, no clear partner disease is found; it is still real and still immune-driven.
Symptoms
Severe pain, often out of proportion to the look of the early lesion – the area hurts deeply, even to light touch.
Rapid enlargement – a small bump or pimple-like spot can become a wide ulcer over days to weeks.
Purple-blue undermined edge – the border looks dusky and “scooped under,” which is very typical for PG.
Raw, wet base with yellowish tissue – the center looks dirty or purulent, but cultures may be sterile.
Tender redness around the ulcer – the surrounding skin looks inflamed and feels warm.
Pustules or blisters that quickly break – the surface is fragile; once it breaks, an ulcer forms.
Pathergy – any poke, tape, or debridement can worsen the ulcer or start a new one nearby.
Multiple ulcers – more than one spot can appear, sometimes on both legs or near a stoma.
Fever or feeling unwell – not always present, but systemic inflammation can cause malaise.
Extreme tenderness to cleaning or dressing changes – routine wound care can be very painful.
Scalloped or cribriform scars after healing – the skin may heal with a pitted, lace-like scar.
Location on the lower legs – shins and calves are common, but PG can occur anywhere.
Ulcer that resists antibiotics – antibiotics alone do not solve PG, which hints it is not a simple infection.
Ulcer that worsens after surgery – a surgical wound that keeps breaking down is a red flag for PG.
Symptoms of a partner disease – diarrhea, abdominal pain, joint pain, or fatigue can signal an associated condition like IBD or arthritis.
Diagnostic tests
A) Physical exam
Full-body skin and ulcer mapping
The clinician looks from head to toe, counts every lesion, notes size, depth, drainage, smell, and exactly where each ulcer sits. This helps track speed of change and checks for patterns like leg-dominant disease or peristomal involvement. It also finds subtle new spots early so treatment can start before they widen.Edge and base inspection with dermatoscopy when safe
The examiner studies the border for that classic purple-blue, undermined shape and the base for slough or granulation tissue. A handheld dermatoscope (like a skin magnifier) may be used gently to look at surface clues. Seeing the undermined violaceous edge supports PG; seeing thick black eschar or punched-out borders may suggest other causes.Pain and allodynia assessment
The clinician asks you to score pain and tests light touch. Pain that is severe even with light contact and seems out of proportion to the early skin change is typical. Tracking pain helps judge whether inflammation is calming with therapy.Comorbidity screen at the bedside
The examiner gently checks joints for swelling or tenderness (arthritis), looks for stoma problems, examines the abdomen for tenderness (IBD clues), and takes basic vitals. This quick screen points to partner diseases that guide the work-up.Infection and vascular red-flag signs
The clinician looks for spreading cellulitis, foul-smelling drainage, crepitus, or black necrosis that might mean a true infection or vascular emergency. PG can sit on top of a secondary infection, so this check is repeated often.
B) Manual tests
Ulcer measurement and serial photography
A paper ruler or planimetry grid measures length, width, and, if appropriate, depth, and photos are taken with scale and date. This very simple method shows whether the ulcer is expanding or shrinking over time, which is key for decisions.Probe-to-bone test (for osteomyelitis)
A sterile blunt probe is gently placed into the ulcer to see if bone can be felt. If bone is touched, infection of bone is more likely and imaging plus deeper cultures may be needed. The test is done carefully to limit trauma.Pulse palpation and capillary refill
The clinician feels the foot pulses and checks how quickly color returns to a blanched toe. Good pulses support adequate arterial inflow; weak or absent pulses push the team to test arteries further, because poor blood flow slows healing even in PG.Ankle-Brachial Index (ABI) at bedside
Blood pressure cuffs on the arm and ankle plus a simple handheld Doppler give a ratio that screens for peripheral artery disease. A low ABI suggests narrowed arteries, which complicates any ulcer. This helps separate “pure PG” from “PG with arterial disease.”Pitting edema test
Gentle pressure over the shin or ankle checks for fluid buildup. Significant edema can stress the skin and slow healing; knowing this guides supportive measures like elevation and compression (only when arteries are adequate and with careful padding).
C) Laboratory and pathological tests
Complete blood count with differential (CBC)
This checks white cells, hemoglobin, and platelets. It can show anemia from chronic disease, high white counts from inflammation, or clues to a blood disorder. It also provides a baseline before immune-calming medicines are used.Inflammation markers: ESR and CRP
These numbers rise with body-wide inflammation. They are not specific, but they track the “fire level.” If treatment works, the values usually fall, which supports the clinical picture.Metabolic panel and glucose
Kidney and liver function tests are needed before and during therapy because many PG medicines use these organs for processing. Blood sugar matters too because high glucose slows wound repair and raises infection risk.Autoimmune and associated disease screen (ANA, RF, anti-CCP, ANCA, etc.)
These blood tests look for partner diseases like rheumatoid arthritis or vasculitides. A positive test does not prove PG, but it can explain joint symptoms and shape the overall treatment plan.Stool tests for inflammatory bowel disease activity (e.g., fecal calprotectin)
When IBD is suspected or known, this non-invasive test helps judge gut inflammation. Skin and gut flares can move together, so this result helps the gastroenterology team tune therapy.Skin biopsy of the ulcer edge with tissue cultures
A small piece is taken from the active edge, not the dead center, and sent for routine histology and sometimes for bacterial, fungal, and mycobacterial cultures. The pathologist often sees a dense neutrophil-rich infiltrate and tissue breakdown; there may be small-vessel inflammation. Cultures help rule out infection. Biopsy must be done gently and only once if possible because trauma can worsen PG (pathergy).
D) Electrodiagnostic tests
Transcutaneous oxygen pressure (TcPO₂)
Small sensor discs on the skin measure how much oxygen reaches the tissue. Low numbers point to poor micro-circulation, which slows healing. This helps separate “hard-to-heal because of blood flow” from “hard-to-heal because of inflammation,” and it guides vascular support.Nerve conduction studies (when neuropathic ulcers are in the differential)
If the ulcer pattern and foot findings could be from diabetic neuropathy rather than PG, nerve tests help prove or rule out significant nerve damage. This matters because neuropathic ulcers are managed differently and do not need strong immune-calming medicines.
E) Imaging tests
Plain X-ray and/or MRI of the involved limb (for bone and deep tissue)
X-rays look for gas in soft tissues, foreign bodies, or bony changes. MRI is much more sensitive for osteomyelitis (bone infection) and for mapping sinus tracts or deep inflammation. Finding or excluding bone infection changes antibiotics, surgery decisions, and the whole plan.Vascular duplex ultrasound of arteries and veins
This test checks arterial flow and looks for deep vein thrombosis or severe venous reflux. Arterial blockages and venous disease do not cause PG, but they strongly affect healing speed and dressing choices, so knowing the vessel status is vital.
Non-Pharmacological Treatments (Therapies & Others)
Below are practical, day-to-day measures. Each item includes a short description, purpose, and mechanism in simple terms.
Gentle wound cleansing
What: Rinse the ulcer with lukewarm normal saline; avoid harsh scrubbing.
Purpose: Lowers surface germs and crusts without irritating the skin.
Mechanism: Saline mechanically lifts debris while keeping the wound moist and calm. FrontiersNon-adherent moist dressings
What: Use non-stick, moist dressings (e.g., silicone foam, petrolatum gauze, lipid-colloid) matched to drainage.
Purpose: Protects tissue, reduces pain when changing, supports healing.
Mechanism: Maintains a warm, moist environment that helps skin cells migrate and reduces trauma on removal. Journal of Investigative Dermatology+1Absorbent dressings when drainage is heavy
What: Hydrofiber, alginate, or foam dressings when the wound is weepy.
Purpose: Controls exudate, limits maceration, and reduces dressing-change frequency.
Mechanism: Absorbs fluid while keeping a moist surface for healing. FrontiersTargeted antimicrobial dressings (short term)
What: Silver or polyhexanide dressings if there is surface bacterial load.
Purpose: Limits bioburden without systemic antibiotics.
Mechanism: Local antimicrobial action reduces colonization that can impede healing. FrontiersPeriwound skin protection
What: Barrier film/creams around the ulcer.
Purpose: Prevents skin breakdown caused by drainage and adhesives.
Mechanism: Forms a thin protective layer that resists moisture and friction. PMCCompression therapy (if arterial flow is adequate)
What: Light to moderate compression wraps/stockings when edema or venous disease coexists.
Purpose: Reduces swelling and improves venous return.
Mechanism: External pressure counters venous hypertension and edema, aiding tissue oxygenation. Journal of Investigative DermatologyElevation and rest for the limb
What: Elevate the affected leg several times daily.
Purpose: Less swelling, less throbbing pain.
Mechanism: Gravity assists venous and lymphatic return.Pain control plan (non-opioid first)
What: Scheduled acetaminophen; adjuncts like gabapentin/duloxetine for neuropathic features; topical lidocaine gel for dressing changes (per clinician advice).
Purpose: Improves comfort and mobility, reduces stress.
Mechanism: Central and peripheral pain modulation; local anaesthetic blunts nerve firing.Avoid trauma and friction (“pathergy prevention”)
What: Loose clothing, careful tape use, slow atraumatic dressing changes; warn providers before procedures.
Purpose: Prevents new ulcers or flares at injury sites.
Mechanism: Minimizes micro-injury that can trigger PG lesions. journals.cambridgemedia.com.auNegative Pressure Wound Therapy (select cases, under immunosuppression)
What: A vacuum dressing set to gentle negative pressure.
Purpose: Helps manage exudate and assists graft take once inflammation is controlled.
Mechanism: Removes excess fluid, reduces edema, and micro-deforms tissue to encourage granulation—only when PG is medically calmed. PMC+1Ostomy/stoma care optimization (for peristomal PG)
What: Skilled pouch fitting, barrier rings, paste, and gentle techniques.
Purpose: Stops leakage and skin irritation that perpetuate ulcers near a stoma.
Mechanism: A clean, sealed appliance reduces chemical and mechanical injury. PubMedLippincottNutritional support for wound healing
What: Adequate calories and protein; correct vitamin/mineral deficits (see supplement section).
Purpose: Supplies building blocks for collagen and immune repair.
Mechanism: Protein and micronutrients fuel cell growth, collagen crosslinking, and immunity.IBD/arthritis co-management
What: Coordinate with gastroenterology/rheumatology.
Purpose: Treating the linked disease helps calm PG.
Mechanism: Shared immune pathways mean controlling systemic inflammation often improves the skin. American Academy of DermatologyPsychological support and sleep hygiene
What: Counseling, peer groups, relaxation techniques.
Purpose: Reduces stress-related flares and improves adherence.
Mechanism: Stress hormones influence immune activity and pain perception.Smoking cessation
What: Stop tobacco and nicotine.
Purpose: Better blood flow and oxygen delivery to tissue.
Mechanism: Nicotine and smoke toxins impair microcirculation and collagen deposition.Glycemic control in diabetes
What: Keep blood sugar within target range.
Purpose: Faster healing and fewer infections.
Mechanism: High glucose impairs leukocyte function and fibroblast activity.Photo documentation and measurement
What: Regular photos and length–width–depth tracking.
Purpose: Objective progress monitoring to adjust care.
Mechanism: Quantifies healing trajectory.Topical anti-inflammatory therapy assistance
What: Occlusive application of high-potency steroid or tacrolimus ointment (ordered by clinician).
Purpose: Dials down local inflammation to reduce pain and tissue destruction.
Mechanism: Steroids block multiple inflammatory signals; tacrolimus inhibits calcineurin and T-cell activation. DermNet®Infection surveillance (but avoid reflex debridement)
What: Watch for cellulitis signs; culture if suspicious.
Purpose: Treat true secondary infection while preventing harmful procedures.
Mechanism: Cultures guide antibiotics if needed; avoiding sharp debridement reduces pathergy. PubMedSurgical timing discipline
What: If reconstruction is needed, do it after inflammation is controlled with systemic therapy.
Purpose: Lowers risk of pathergy and graft failure.
Mechanism: Immunosuppression quiets the immune attack so tissue can accept grafts/flaps. PMC
Drug Treatments
Important: Doses are typical starting points for adults and may change with weight, kidney/liver function, other illnesses, and drug interactions. Always individualize with your clinician.
Systemic corticosteroid (Prednisone/Prednisolone) — Glucocorticoid
Dose/Time: ~0.5–1 mg/kg/day; reassess in 1–2 weeks; taper as response allows.
Purpose: Rapid control of active, painful ulcer inflammation.
Mechanism: Broad anti-inflammatory and immunosuppressive effects.
Side effects: Weight gain, mood changes, hyperglycemia, hypertension, infection risk, osteoporosis.
Evidence note: Standard first-line; comparable healing to ciclosporin in RCT (STOP GAP). BMJWiley Online LibraryCiclosporin (Cyclosporine) — Calcineurin inhibitor
Dose/Time: ~3–5 mg/kg/day in divided doses; monitor creatinine and BP; usually months.
Purpose: Steroid-sparing control of PG.
Mechanism: Blocks T-cell activation via calcineurin inhibition.
Side effects: Kidney toxicity, hypertension, tremor, gingival hyperplasia.
Evidence: Similar effectiveness to prednisolone in pragmatic RCT; choice often based on comorbidities/tolerance. BMJWiley Online LibraryTopical high-potency corticosteroid (e.g., Clobetasol 0.05% under occlusion) — Topical steroid
Dose/Time: Thin layer 1–2×/day to ulcer edge/periwound as directed.
Purpose: Reduce local inflammation and pain.
Mechanism: Local glucocorticoid effect.
Side effects: Skin atrophy, telangiectasia with prolonged use. DermNet®Topical Tacrolimus 0.1% ointment — Topical calcineurin inhibitor
Dose/Time: 1–2×/day to active margins/peristomal areas.
Purpose: Useful where steroids are risky (thin skin, peristomal sites).
Mechanism: Local T-cell suppression without steroid atrophy.
Side effects: Burning/tingling at application site. Best Wound PracticeDapsone — Anti-neutrophilic / anti-inflammatory sulfone
Dose/Time: Often 50–200 mg/day; check G6PD before starting.
Purpose: Steroid-sparing option for mild–moderate disease or adjunct.
Mechanism: Inhibits neutrophil function and myeloperoxidase activity.
Side effects: Hemolysis (esp. in G6PD deficiency), methemoglobinemia, rash.Mycophenolate Mofetil (MMF) — Antimetabolite immunosuppressant
Dose/Time: 1–3 g/day divided; months as steroid-sparing therapy.
Purpose: Maintenance immunosuppression.
Mechanism: Inhibits inosine monophosphate dehydrogenase → lowers lymphocyte proliferation.
Side effects: GI upset, leukopenia, infection risk.Azathioprine — Antimetabolite
Dose/Time: ~1–2.5 mg/kg/day; test TPMT/NUDT15 activity if available.
Purpose: Maintenance steroid-sparing therapy, especially with IBD.
Mechanism: Purine synthesis blockade → fewer activated lymphocytes.
Side effects: Bone marrow suppression, hepatotoxicity, pancreatitis; drug interactions (e.g., allopurinol).Colchicine — Anti-neutrophil microtubule inhibitor
Dose/Time: 0.6 mg 1–2×/day as adjunct.
Purpose: Additional control of neutrophil-driven inflammation.
Mechanism: Disrupts microtubules → reduces neutrophil chemotaxis.
Side effects: GI upset, myopathy (esp. with statins) at higher doses.Minocycline — Tetracycline antibiotic with anti-inflammatory effects
Dose/Time: 100 mg twice daily initially.
Purpose: Adjunct for inflammatory control when immunosuppression risks are high.
Mechanism: Inhibits matrix metalloproteinases and neutrophil activity.
Side effects: Dizziness, pigmentation changes, drug-induced lupus (rare).Intralesional Triamcinolone — Corticosteroid injection
Dose/Time: Dilute triamcinolone injected into raised borders at intervals (specialist use).
Purpose: Suppress intensely inflamed edges without high systemic doses.
Mechanism: Local steroid effects.
Side effects: Skin atrophy, telangiectasia.
Why not list biologics here? I include the major biologics and advanced immuno-regenerative options in the next section, as you asked for a separate “hard immunity booster / regenerative / stem cell drugs” group. Evidence for these agents in PG includes a randomized, placebo-controlled trial for infliximab and extensive real-world/series data for others. PMC
Regenerative / Stem-Cell–Related” Drugs
These are advanced, off-label options often used when first-line therapy fails or when there is severe PG with systemic disease. Dosing often follows regimens approved for other diseases; specialists individualize.
Infliximab — Anti-TNF-α monoclonal antibody (biologic)
Dose/Time: 5 mg/kg IV at weeks 0, 2, 6, then every 8 weeks (typical).
Purpose: Rapid control of severe, refractory PG, especially with IBD.
Mechanism: Neutralizes TNF-α, a key cytokine driving neutrophil-rich inflammation.
Side effects: Infusion reactions, serious infections (TB reactivation screening required), heart failure caution.
Evidence: First randomized, placebo-controlled PG trial showed superiority to placebo. PMCPubMedAdalimumab — Anti-TNF-α (biologic)
Dose/Time: Common off-label pattern: 160 mg day 1, 80 mg day 15, then 40 mg weekly or every 2 weeks (specialist decides).
Purpose: Alternative to infliximab for TNF blockade.
Mechanism/Side effects: As above (subcutaneous route).
Evidence: Case series support efficacy in refractory PG, particularly with IBD. IR JournalUstekinumab — IL-12/23 blocker (biologic)
Dose/Time: Psoriasis dosing (45–90 mg at week 0 and 4, then q12wk) or Crohn’s IV induction ~6 mg/kg then 90 mg SC q8wk; specialist-guided.
Purpose: For cases linked to IBD or when TNF inhibitors fail.
Mechanism: Blocks p40 subunit shared by IL-12 and IL-23 → reduces Th1/Th17 pathways.
Side effects: Infection risk; consider TB/viral screening.
Evidence: Growing case-series support; used when TNF inhibitors are not suitable.Anakinra / Canakinumab — IL-1 pathway inhibitors
Dose/Time: Anakinra 100 mg SC daily; canakinumab 150 mg SC every 4–8 weeks (specialist use).
Purpose: For PG with autoinflammatory features or when other biologics fail.
Mechanism: IL-1 blockade dampens neutrophil-driven inflammation.
Side effects: Injection reactions, infections.
Evidence: Case reports/series indicate benefit in refractory PG. (Illustrative; limited but growing.)Tofacitinib — JAK inhibitor
Dose/Time: 5 mg twice daily (or 10 mg BID short-term induction) under specialist monitoring.
Purpose: Rescue in refractory PG, especially with concomitant IBD.
Mechanism: Blocks JAK-STAT signaling to multiple cytokines.
Side effects: Herpes zoster, lipid elevation, thrombosis risk at higher doses; monitoring required.
Evidence: Emerging case-series experience; off-label.Intravenous Immunoglobulin (IVIG) — Immunomodulator derived from pooled IgG
Dose/Time: Common regimen 2 g/kg total per cycle over 2–5 days monthly for several cycles.
Purpose: Rescue therapy when multiple agents fail.
Mechanism: Complex immune modulation (Fc receptor blocking, anti-idiotype effects) that calms auto-inflammation.
Side effects: Headache, aseptic meningitis (rare), thrombosis risk.
About stem cells/regenerative approaches: A few case reports describe mesenchymal stem cell therapy or hematopoietic stem cell transplantation improving PG (often by controlling severe underlying IBD), but these are experimental and not standard of care for PG itself. Any such therapy should occur only in clinical trials or highly specialized centers. @WalshMedicalPMCMedical Journals
Dietary Molecular Supplements
These support general wound healing and nutritional status. Always review with your clinician, especially if you have IBD, kidney disease, or are on anticoagulants.
Protein / Essential Amino Acids
Dose: Aim 1.2–1.5 g/kg/day total protein from food + supplements as needed.
Function/Mechanism: Supplies building blocks for collagen and immune proteins; speeds granulation.Arginine
Dose: ~3–9 g/day in divided doses.
Function: Substrate for nitric oxide; supports collagen and immune responses.
Mechanism: Improves local blood flow and fibroblast activity.Glutamine
Dose: ~0.2–0.3 g/kg/day.
Function: Fuel for rapidly dividing cells and immune cells.
Mechanism: Supports mucosal and wound cell metabolism.Vitamin C (Ascorbic acid)
Dose: 500 mg twice daily (or per deficiency).
Function: Collagen crosslinking and antioxidant defense.
Mechanism: Hydroxylates proline/lysine in collagen; scavenges free radicals.Zinc (elemental)
Dose: 30–50 mg/day short term; recheck levels; add copper if >2–3 months.
Function: Enzyme cofactor for DNA synthesis and epithelial repair.
Mechanism: Supports keratinocyte migration and immune function.Vitamin D
Dose: 1000–2000 IU/day (adjust to blood level).
Function: Immune modulation and bone health during steroids.
Mechanism: Influences innate/adaptive immunity and cytokines.Omega-3 (EPA/DHA)
Dose: 2–4 g/day combined EPA+DHA.
Function: Anti-inflammatory lipid mediators.
Mechanism: Shifts eicosanoid balance away from pro-inflammatory pathways.Multivitamin with minerals
Dose: 1 daily.
Function: Covers small deficiencies (A, E, B-complex, selenium) that can slow repair.
Mechanism: Cofactors for cell growth and antioxidant enzymes.Probiotics (IBD-linked cases)
Dose: Product-specific (e.g., Lactobacillus/Bifidobacterium as labeled).
Function: Gut microbiome support that may help systemic inflammation in IBD-associated PG.
Mechanism: Competes with harmful bacteria; modulates mucosal immunity.Curcumin (Turmeric extract)
Dose: 500–1000 mg curcumin twice daily with piperine (if tolerated).
Function: Anti-inflammatory adjunct.
Mechanism: Inhibits NF-κB and cytokine signaling.
Note: Evidence for supplements in PG specifically is limited; their role is supportive, especially when overall nutrition is poor or IBD is active.
Surgeries
Surgery is not first-line. It is considered after inflammation is controlled with systemic therapy, because active PG can flare with trauma.
Split-Thickness Skin Grafting (STSG)
What: Thin shaved skin is placed over a clean, granulating ulcer bed.
Why: Speeds closure of large, stable wounds after medical control.
Notes: Often secured with gentle negative pressure; timing is crucial to avoid pathergy. PMCFlap Reconstruction
What: Nearby tissue is moved to cover a defect.
Why: Provides durable coverage where tendons/bone are exposed.
Notes: Only when disease is quiet; immunosuppression should be optimized.Limited, conservative debridement
What: Careful removal of loose necrotic debris without cutting into healthy inflamed edges.
Why: To control odor/exudate if truly necessary under immunosuppression.
Notes: Aggressive debridement is contraindicated due to pathergy risk. PubMedScienceDirectStoma appliance revision / relocation (peristomal PG only)
What: Surgical adjustment or, rarely, relocation of a problematic stoma.
Why: Persistent leakage or appliance failure causing ongoing skin injury.
Notes: Relocation is last resort; PG can recur at the new site. LippincottAdjunctive Negative Pressure Wound Therapy (peri-op)
What: VAC device over graft/flap to support take and manage exudate.
Why: Stabilizes dressings and promotes granulation after inflammation is controlled.
Notes: Pain and skin irritation are possible; use expertly. JAMA Network
Preventions
We cannot fully “prevent” PG, but we can reduce flare risk:
Tell every clinician you have PG before blood draws, injections, or surgery (pathergy risk). journals.cambridgemedia.com.au
Avoid skin trauma: gentle adhesives, protective clothing, careful shaving.
Manage linked diseases (IBD, arthritis) with your specialists; flares can trigger PG. American Academy of Dermatology
Stay on maintenance meds as prescribed; do not stop abruptly.
Optimize stoma care if you have an ostomy; fix leaks early. PubMed
Control swelling (elevation, compression if safe).
Stop smoking and limit alcohol.
Keep blood sugar controlled if you have diabetes.
Nourish your body: enough protein, vitamins, fluids.
Treat minor skin injuries early with gentle cleansing and non-adherent cover.
When to See a Doctor (red flags)
Rapidly enlarging, very painful ulcer with purple undermined borders—especially on the legs or near a stoma.
New ulcers after minor trauma or surgery (possible pathergy).
Fever, spreading redness, foul smell, or pus, which may signal secondary infection that needs attention.
Severe pain not controlled with simple measures.
Side effects from steroids or immunosuppressants (e.g., high sugar, blood pressure, signs of infection).
Known IBD or arthritis plus new ulcers—these conditions often travel together and should be co-managed. Bad Association
Foods/Patterns to Favor—and to Limit
Goal: Support healing, steady energy, and immune balance. If you have IBD, tailor choices with your gastroenterologist.
Eat more :
Lean proteins (fish, eggs, poultry, tofu) for tissue repair.
Dairy or alternatives (as tolerated) for protein + calcium (helps during steroid use).
Legumes (if tolerated) for protein and micronutrients.
Colorful vegetables (cooked if IBD flaring) for vitamins A/C/K and antioxidants.
Fruits (peeled/cooked if needed) for vitamin C and polyphenols.
Whole grains (or low-residue options during IBD flares) for energy and B-vitamins.
Healthy fats (olive oil, nuts, seeds) for calories and omega-3 precursors.
Fatty fish (salmon, sardines) for EPA/DHA.
Hydration (water; broths) to support perfusion and skin turgor.
Fermented foods (yogurt/kefir) if tolerated.
Limit :
Smoking and nicotine (impairs healing).
Excess alcohol (dehydrates, affects immunity).
Very high-sugar foods/drinks (glycemic spikes can impair healing).
Ultra-processed foods (pro-inflammatory additives).
Trans fats (inflammation).
Excess salt if you have edema or hypertension.
NSAIDs without medical advice (may worsen IBD and bleeding risk).
Trigger foods that flare your IBD (personalized).
Very spicy/acidic foods if they aggravate symptoms.
Mega-dosing supplements without testing or supervision.
Frequently Asked Questions
Is PG an infection?
No. PG is inflammatory, not infectious, and it is not contagious. Antibiotics help only if there is a true secondary infection. Bad AssociationWhat causes it?
We don’t know the single cause. It is an immune system over-reaction often linked with diseases like IBD or arthritis. NCBIHow is PG diagnosed?
There is no single test. Doctors rely on the history, exam, biopsy to rule out other causes, and lab/imaging to exclude infection, vascular disease, and cancer. Dermatology input is essential. PMCWhy do ulcers grow after minor injuries?
This is pathergy—the immune system over-reacts to small trauma, causing new or bigger ulcers. journals.cambridgemedia.com.auCan I have surgery or debridement?
Avoid sharp debridement while PG is active because it can worsen ulcers. If surgery is needed (e.g., graft), do it after medical control, under specialist care. PubMedPMCWhat is first-line treatment?
Systemic steroids or ciclosporin are common first steps; both can work, and choice depends on your situation. BMJWhen do biologics come in?
For severe or refractory PG, especially with IBD, anti-TNF (e.g., infliximab) and other biologics can be highly effective. PMCHow long does healing take?
It varies—weeks to months. Early treatment, good wound care, and controlling comorbidities speed healing.Will I have scars?
Yes, healed PG often leaves cribriform (criss-cross) scars and color changes. Scar management can help appearance.Can children get PG?
Yes, but it’s uncommon. They also need evaluation for underlying conditions.Is PG related to cancer?
Most cases are not cancer, but doctors may check for blood disorders in some patients because of known associations.Can stress make it worse?
Stress can amplify pain and immune activity; managing stress helps overall control.What about pregnancy?
PG can occur in pregnancy/postpartum; treatment choices are adjusted for safety—specialist teams will guide you.Do I need antibiotics?
Only if there is proven infection. PG itself is not bacterial. Overuse of antibiotics is avoided.What’s the outlook?
With the right plan, most people improve and heal, but relapses can occur. A long-term maintenance strategy and quick action at early signs give the best outcomes.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 23, 2025.
